CNS-3D Brain Organoids Predict Clinical Seizure Liability Central nervous system (CNS) toxicity accounts for 25% of safety ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology company, to advance ...

The MarketWatch News Department was not involved in the creation of this content.-- Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gen ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel ...

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gene expression, pathway activity, and cell states ...

Even when bacteria appear susceptible in routine tests, tolerance can let them survive therapy long enough to drive ...

Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research (AACR) Annual ...

At the 2026 American Association for Cancer Research (AACR) Annual Meeting, InnoCare Pharma (HKEX: 9969; SSE: 688428) presented preclinical data of its novel B7-H3 targeted ADC ICP-B794. The research ...

Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...

CareDx CDNA recently announced the launch of AlloSeq Nano, a nanopore-based HLA (human leukocyte antigen) and ABO genotyping ...